Details
|
CTIC (a biopharmaceutical company) works on developing an integrated portfolio of oncology products, helping make cancer more treatable. The company develops, acquires, and commercializes products for treatment of cancer. Cell therapeutics major drug-trisenox or arsenic trioxide, is used for the treatment of refractory or relapsed acute promyelocytic leukemia. The industry also develops Xyotax-a polyglutamate polymer, prescribed for possible treatment of nonsmall cell lung cancer, as well as ovarian cancer. It uses a biodegradable protein polymer to deliver the chemotherapy paclitaxel directly to tumor tissue. CTIC also has a product such as Pixantrone that is currently in processing stages of development. Once it is approved it will be used for potential treatment of relapsed aggressive non-hodgkin’s lymphoma. Cell Therapeuticals operates in the United States and Italy. The company was discovered by James Bianco, Jack Singer and Louis Bianco in 1991 and is located in Seattle, Washington.
|
